SCHEMBL3393388

SCHEMBL3393388

CC(C)[Si](Oc1ccc2c(c1)S(O)(O)N=C(CC(=O)O)N2)(C(C)C)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.33
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3393385 0.89 ALDH1A1 (0.48) ALDH1A1LMNA
SCHEMBL3392363 0.84 KDM4E (0.43) LMNAKDM4E
SCHEMBL3391447 0.77 MAOB (0.44) ALDH1A1KDM4E
SCHEMBL3389375 0.76 CA2 (0.40) ALDH1A1LMNA
SCHEMBL3395055 0.75 AKR1C2 (0.43) ALDH1A1KDM4E
SCHEMBL3392351 0.72 MAPT (0.46) ALDH1A1LMNAKDM4E
SCHEMBL3395053 0.72 ALDH1A1 (0.48) ALDH1A1LMNA
SCHEMBL1523451 0.71 ALDH1A1 (0.37) ALDH1A1LMNAKDM4E
SCHEMBL15033738 0.67 POLB (0.46) ALDH1A1LMNAKDM4E
SCHEMBL3391436 0.66 MEN1 (0.49) ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1560827-B1 ANTI-INFECTIVE AGENTS ABBOTT LAB (US) 2010-12-29 EP disclosed
US-20050075331-A1 Anti-infective agents ABBOTT LABORATORIES 2005-04-07 US disclosed
US-20040167123-A1 Anti-infective agents ABBVIE INC. 2004-08-26 US disclosed
US-20040162285-A1 Anti-infective agents ABBOTT LABORATORIES 2004-08-19 US disclosed
US-20040087577-A1 Anti-infective agents ABBOTT LABORATORIES 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162285-A1 Anti-infective agents POLR1C, RPL5, POLB ALDH1A1 1434/4885LMNA 3232/4885KDM4E 4352/4885
US-20040167123-A1 Anti-infective agents SERPINB1, CYP51A1, ZC3HAV1 ALDH1A1 891/4885LMNA 4000/4885KDM4E 4075/4885
US-20050075331-A1 Anti-infective agents RPL35, POLI, POLRMT ALDH1A1 1592/4885LMNA 4225/4885KDM4E 3897/4885
US-20040087577-A1 Anti-infective agents POLR1C, RPL5, POLB ALDH1A1 1434/4885LMNA 3232/4885KDM4E 4352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.